Survey Reveals 90%+ Bladder Cancer Patients Report Treatment Burden, 76% Cite Humiliation
A global survey of 817 bladder cancer patients found over 90% of patients post-cystectomy or BCG report negative impacts on daily activities, with 76% describing BCG-related symptoms as humiliating. Nearly 40% of urologists regret recommending cystectomy and 75% of patients conceal their emotional burden, highlighting demand for patient-centric therapies.
1. Survey Scope and Methodology
The global survey polled 817 patients with non–muscle-invasive bladder cancer and 802 urologists in the United States, Mexico, Brazil, Japan, Germany and France to evaluate experiences with radical cystectomy and BCG therapy across physical, emotional and daily life domains.
2. Patient-Reported Burden
More than 90% of patients who underwent cystectomy or BCG reported moderate to significant negative impacts on daily activities, body image and self-esteem, with 76% describing BCG-related symptoms as humiliating and 94% missing key life moments such as socializing or leaving home.
3. Urologist Regret and Innovation Demand
Nearly 40% of urologists who recommended cystectomy said they regretted the decision, and both patients and physicians expressed strong desire for treatments that reduce quality-of-life disruptions and address emotional well-being, underscoring unmet need for more patient-centric options.